查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1968709

數位生物製造市場分析及預測（至2035年）：按類型、產品類型、服務、技術、組件、應用、流程、部署類型、最終用戶和解決方案分類

Digital Biomanufacturing Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Component, Application, Process, Deployment, End User, Solutions
出版日期: | 出版商: Global Insight Services | 英文 353 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

數位生物製造市場預計將從2024年的28億美元成長到2034年的151億美元，複合年成長率約為18.4%。數位生物製造市場涵蓋將數位技術整合到生物生產過程中，以提高效率、精確度和擴充性。該市場利用數據分析、機器學習和物聯網來最佳化生物製程、降低成本並提高產品品質。對個人化醫療和永續生產日益成長的需求正在推動自動化、即時監控和預測建模方面的創新，從而促進市場成長。

受生物技術和自動化進步的推動，數位化生物製造市場正經歷強勁成長。在產品細分市場中，生物加工設備表現最為突出，它們對於最佳化生產效率和產品品質至關重要。生物反應器和發酵槽在推動可擴展生物製造製程創新方面發揮關鍵作用。軟體細分市場（包括數據分析和製程控制解決方案）是成長第二快的細分市場，這反映了對生物製造操作進行精確監控和最佳化的需求。在應用細分市場中，藥物研發和生產佔據主導地位，這主要得益於對生物製藥和個人化醫療日益成長的需求。細胞和基因治療製造是成長第二快的細分市場，其成長動力來自再生醫學和標靶治療的進步。這些領域中數位技術的整合提高了流程透明度，縮短了產品上市時間，並提高了對嚴格監管標準的合規性。對數位雙胞胎和人工智慧驅動的生物加工的投資正在進一步加速市場成長，為相關人員提供了盈利的機會。

市場區隔
類型 連續生物製造、間歇生物製造、混合生物製造
產品 生物反應器、一次性系統、層析法系統、過濾系統、離心機、混合系統、細胞培養基、緩衝液和試劑
服務 流程開發、諮詢、訓練、維護與支援、品質保證、法規遵循、數據分析
科技 機器學習、人工智慧、物聯網、區塊鏈、數位雙胞胎、3D生物列印、雲端運算、巨量資料分析
成分 軟體、硬體和生物組件
應用領域 藥品、生物製藥、基因療法、細胞療法、疫苗生產、酵素生產、生質燃料
過程 上游工程、下游製程、配方、包裝
實施表格 本機部署、雲端部署、混合式部署
最終用戶 生技公司、製藥公司、研究機構、學術機構、契約製造組織
解決方案 整合式、獨立式和客製化解決方案

市場概況：

受競爭性定價策略和創新產品推出的影響，數位生物製造市場正經歷著市場佔有率的動態變化。各公司正透過利用先進的生物技術和推出前沿解決方案來鞏固其市場地位。該市場的特點是產品多樣化，各公司既注重成本效益，也注重技術優勢。策略夥伴關係和聯盟進一步塑造了這種競爭格局，它們在推動創新和拓展產品系列發揮關鍵作用。對數位生物製造市場的競爭基準分析表明，主要行業參與者佔據主導地位，並積極塑造市場趨勢。監管影響，特別是北美和歐洲嚴格的合規要求，對制定市場標準至關重要。亞太地區正崛起為投資熱點，這得益於有利的法規結構和政府主導的措施。隨著市場的不斷發展，數位技術和自動化的整合有望推動成長，並在監管挑戰中為相關人員提供豐厚的成長機會。

主要趨勢和促進因素：

受自動化和人工智慧技術進步的推動，數位生物製造市場正經歷強勁成長。這些技術正在革新生產流程，提高效率並降低成本。物聯網設備的整合也是關鍵趨勢，它實現了對生物過程的即時監控。這種連接性有助於數據驅動的決策，進而最佳化生產結果。此外，對個人化醫療日益成長的需求也在推動市場發展，因為數位生物製造能夠實現大規模客製化生產。監管機構也越來越支持這一領域，他們認知到數位生物製造在藥物研發方面具有創新和提高效率的潛力。永續性也是一個關鍵促進因素，數位化解決方案能夠減少生物製造過程中的廢棄物和能源消耗。人們對合成生物學的興趣日益濃厚，這正在拓展數位生物製造的潛在應用。企業正在加大研發投入，以充分利用這些技術，從而為新產品開發創造機會。隨著產業的不斷發展，夥伴關係關係不斷湧現，推動了創新和市場擴張。

限制與挑戰：

數位生物製造市場面臨許多顯著的限制和挑戰。其中一個主要挑戰是尖端數位技術所需的高額初始投資，這阻礙了中小企業進入市場。此外，將數位系統與現有生物製造流程整合通常需要專業知識，這構成了一道重要的技術壁壘。資料安全和隱私問題也是一大障礙，因為整合數位系統會增加網路威脅和資料外洩的風險。合規性同樣是一項重大挑戰，因為遵守複雜的國際監管環境既耗時又昂貴。此外，能夠操作和維護先進數位生物製造系統的熟練人員短缺。這種技能缺口會導致效率低下，並阻礙新技術的有效應用。所有這些因素共同構成了數位生物製造領域市場成長和創新的重大障礙。

目錄

第1章執行摘要

第2章 市場亮點

第3章 市場動態

  • 宏觀經濟分析
  • 市場趨勢
  • 市場促進因素
  • 市場機遇
  • 市場限制
  • 複合年均成長率：成長分析
  • 影響分析
  • 新興市場
  • 技術藍圖
  • 戰略框架

第4章 細分市場分析

  • 市場規模及預測：依類型
    • 連續生物製造
    • 批次式生物製造
    • 混合生物製造
  • 市場規模及預測：依產品分類
    • 生物反應器
    • 免洗系統
    • 層析法系統
    • 過濾系統
    • 離心機
    • 混合系統
    • 細胞培養基
    • 緩衝液和試劑
  • 市場規模及預測：依服務分類
    • 製程開發
    • 諮詢
    • 訓練
    • 維護和支援
    • 品質保證
    • 監理合規
    • 數據分析
  • 市場規模及預測：依技術分類
    • 機器學習
    • 人工智慧
    • 物聯網 (IoT)
    • 區塊鏈
    • 數位雙胞胎
    • 3D生物列印
    • 雲端運算
    • 巨量資料分析
  • 市場規模及預測：依組件分類
    • 軟體
    • 硬體
    • 生物成分
  • 市場規模及預測：依應用領域分類
    • 製藥
    • 生物製藥
    • 基因治療
    • 細胞療法
    • 疫苗生產
    • 酵素的生產
    • 生質燃料
  • 市場規模及預測：依製程分類
    • 上游工程
    • 下游工藝
    • 配方
    • 包裝
  • 市場規模及預測：依發展狀況
    • 本地部署
    • 基於雲端的
    • 混合
  • 市場規模及預測：依最終用戶分類
    • 生技公司
    • 製藥公司
    • 研究機構
    • 學術機構
    • 契約製造組織（CMO）
  • 市場規模及預測：按解決方案分類
    • 整合解決方案
    • 獨立解決方案
    • 客製化解決方案

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地區
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 台灣
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他歐洲地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 撒哈拉以南非洲
    • 其他中東和非洲地區

第6章 市場策略

  • 需求與供給差距分析
  • 貿易和物流限制
  • 價格、成本和利潤率趨勢
  • 市場滲透率
  • 消費者分析
  • 法規概述

第7章 競爭訊息

  • 市場定位
  • 市場占有率
  • 競爭基準
  • 主要企業的策略

第8章 公司簡介

  • Ginkgo Bioworks
  • Zymergen
  • Arzeda
  • Amyris
  • Conagen
  • Genomatica
  • Pivot Bio
  • Synthace
  • Benchling
  • Inscripta
  • Twist Bioscience
  • Cambrium
  • Evonetix
  • Cellibre
  • Molecular Assemblies

第9章：關於我們

簡介目錄
Product Code: GIS33788

Digital Biomanufacturing Market is anticipated to expand from $2.8 billion in 2024 to $15.1 billion by 2034, growing at a CAGR of approximately 18.4%. The Digital Biomanufacturing Market encompasses the integration of digital technologies in bioproduction processes, enhancing efficiency, precision, and scalability. This market leverages data analytics, machine learning, and IoT to optimize bioprocesses, reduce costs, and improve product quality. The rising demand for personalized medicine and sustainable production fuels innovation in automation, real-time monitoring, and predictive modeling, driving market growth.

The Digital Biomanufacturing Market is experiencing robust growth, fueled by advancements in biotechnology and automation. Within the product segment, bioprocessing equipment emerges as the top performer, essential for optimizing production efficiency and product quality. Bioreactors and fermenters are pivotal, driving innovation in scalable biomanufacturing processes. The software segment, encompassing data analytics and process control solutions, is the second highest-performing, reflecting the need for precise monitoring and optimization of biomanufacturing operations. In the application segment, drug development and production lead, driven by the increasing demand for biologics and personalized medicine. The second highest-performing sub-segment is cell and gene therapy manufacturing, propelled by breakthroughs in regenerative medicine and targeted therapies. The integration of digital technologies in these areas enhances process transparency, reduces time-to-market, and improves compliance with stringent regulatory standards. Investments in digital twins and AI-driven bioprocessing are further accelerating market growth, offering lucrative opportunities for stakeholders.

Market Segmentation
TypeContinuous Biomanufacturing, Batch Biomanufacturing, Hybrid Biomanufacturing
ProductBioreactors, Single-use Systems, Chromatography Systems, Filtration Systems, Centrifuges, Mixing Systems, Cell Culture Media, Buffers and Reagents
ServicesProcess Development, Consulting, Training, Maintenance and Support, Quality Assurance, Regulatory Compliance, Data Analytics
TechnologyMachine Learning, Artificial Intelligence, Internet of Things, Blockchain, Digital Twin, 3D Bioprinting, Cloud Computing, Big Data Analytics
ComponentSoftware, Hardware, Biological Components
ApplicationPharmaceuticals, Biopharmaceuticals, Gene Therapy, Cell Therapy, Vaccine Production, Enzyme Production, Biofuels
ProcessUpstream Processing, Downstream Processing, Formulation, Packaging
DeploymentOn-premise, Cloud-based, Hybrid
End UserBiotechnology Companies, Pharmaceutical Companies, Research Organizations, Academic Institutions, Contract Manufacturing Organizations
SolutionsIntegrated Solutions, Standalone Solutions, Customized Solutions

Market Snapshot:

Digital biomanufacturing is witnessing a dynamic shift in market share, influenced by competitive pricing strategies and innovative product launches. Companies are leveraging advanced biotechnologies to introduce cutting-edge solutions, enhancing their market position. The market is characterized by a diverse range of offerings, with firms focusing on both cost-effectiveness and technological superiority. This competitive landscape is further shaped by strategic partnerships and alliances, which are pivotal in driving innovation and expanding product portfolios. The competitive benchmarking in the digital biomanufacturing market reveals a landscape dominated by key industry players who are actively shaping market dynamics. Regulatory influences, particularly stringent compliance requirements in North America and Europe, are critical in setting market standards. The Asia-Pacific region is emerging as a hotspot for investment, driven by favorable regulatory frameworks and government initiatives. As the market evolves, the integration of digital technologies and automation is expected to propel growth, offering lucrative opportunities for stakeholders amidst regulatory challenges.

Geographical Overview:

The Digital Biomanufacturing Market is witnessing notable growth across various regions, each presenting unique opportunities. North America leads the market, driven by robust investments in biotechnology and advanced manufacturing technologies. The region benefits from a strong ecosystem of research institutions and biotech firms, fostering innovation and market expansion. Europe follows as a key player, with substantial investments in sustainable biomanufacturing practices. The region's focus on reducing carbon footprints and promoting green technologies enhances its market position. In the Asia Pacific, rapid technological advancements and increasing demand for biologics drive market growth. Countries like China and India are emerging as significant contributors, with government support and expanding biopharmaceutical sectors. Latin America and the Middle East & Africa are emerging markets with growing potential. In Latin America, the rising emphasis on healthcare and biotechnology investments is propelling the market. Meanwhile, the Middle East & Africa are recognizing digital biomanufacturing's role in advancing healthcare and economic development.

Key Trends and Drivers:

The Digital Biomanufacturing Market is experiencing robust growth fueled by advancements in automation and artificial intelligence. These technologies are revolutionizing the production processes, enhancing efficiency, and reducing costs. The integration of IoT devices is another trend, enabling real-time monitoring and control of bioprocesses. This connectivity facilitates data-driven decision-making, optimizing production outcomes. Moreover, the growing demand for personalized medicine is driving the market, as digital biomanufacturing allows for tailored production at scale. Regulatory bodies are increasingly supportive, recognizing the potential for innovation and efficiency in drug development. Sustainability is also a key driver, with digital solutions reducing waste and energy consumption in biomanufacturing processes. There is a rising interest in synthetic biology, which is expanding the potential applications of digital biomanufacturing. Companies are investing in R&D to harness these technologies, creating opportunities for new product development. As the industry evolves, partnerships and collaborations are emerging, fostering innovation and market expansion.

Restraints and Challenges:

The digital biomanufacturing market encounters several notable restraints and challenges. A primary challenge is the high initial investment required for cutting-edge digital technologies, which can deter smaller enterprises from entering the market. Additionally, the complexity of integrating digital systems with existing biomanufacturing processes poses significant technical hurdles, often necessitating specialized expertise. Data security and privacy concerns also present formidable obstacles, as the integration of digital systems increases the risk of cyber threats and data breaches. Regulatory compliance is another critical challenge, as navigating the intricate landscape of global regulations can be both time-consuming and costly. Furthermore, there is a scarcity of skilled professionals capable of operating and maintaining advanced digital biomanufacturing systems. This skills gap can lead to inefficiencies and hinder the effective adoption of new technologies. Collectively, these factors create substantial barriers to market growth and innovation in digital biomanufacturing.

Key Players:

Ginkgo Bioworks, Zymergen, Arzeda, Amyris, Conagen, Genomatica, Pivot Bio, Synthace, Benchling, Inscripta, Twist Bioscience, Cambrium, Evonetix, Cellibre, Molecular Assemblies

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Component
  • 2.6 Key Market Highlights by Application
  • 2.7 Key Market Highlights by Process
  • 2.8 Key Market Highlights by Deployment
  • 2.9 Key Market Highlights by End User
  • 2.10 Key Market Highlights by Solutions

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Continuous Biomanufacturing
    • 4.1.2 Batch Biomanufacturing
    • 4.1.3 Hybrid Biomanufacturing
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Bioreactors
    • 4.2.2 Single-use Systems
    • 4.2.3 Chromatography Systems
    • 4.2.4 Filtration Systems
    • 4.2.5 Centrifuges
    • 4.2.6 Mixing Systems
    • 4.2.7 Cell Culture Media
    • 4.2.8 Buffers and Reagents
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Process Development
    • 4.3.2 Consulting
    • 4.3.3 Training
    • 4.3.4 Maintenance and Support
    • 4.3.5 Quality Assurance
    • 4.3.6 Regulatory Compliance
    • 4.3.7 Data Analytics
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Machine Learning
    • 4.4.2 Artificial Intelligence
    • 4.4.3 Internet of Things
    • 4.4.4 Blockchain
    • 4.4.5 Digital Twin
    • 4.4.6 3D Bioprinting
    • 4.4.7 Cloud Computing
    • 4.4.8 Big Data Analytics
  • 4.5 Market Size & Forecast by Component (2020-2035)
    • 4.5.1 Software
    • 4.5.2 Hardware
    • 4.5.3 Biological Components
  • 4.6 Market Size & Forecast by Application (2020-2035)
    • 4.6.1 Pharmaceuticals
    • 4.6.2 Biopharmaceuticals
    • 4.6.3 Gene Therapy
    • 4.6.4 Cell Therapy
    • 4.6.5 Vaccine Production
    • 4.6.6 Enzyme Production
    • 4.6.7 Biofuels
  • 4.7 Market Size & Forecast by Process (2020-2035)
    • 4.7.1 Upstream Processing
    • 4.7.2 Downstream Processing
    • 4.7.3 Formulation
    • 4.7.4 Packaging
  • 4.8 Market Size & Forecast by Deployment (2020-2035)
    • 4.8.1 On-premise
    • 4.8.2 Cloud-based
    • 4.8.3 Hybrid
  • 4.9 Market Size & Forecast by End User (2020-2035)
    • 4.9.1 Biotechnology Companies
    • 4.9.2 Pharmaceutical Companies
    • 4.9.3 Research Organizations
    • 4.9.4 Academic Institutions
    • 4.9.5 Contract Manufacturing Organizations
  • 4.10 Market Size & Forecast by Solutions (2020-2035)
    • 4.10.1 Integrated Solutions
    • 4.10.2 Standalone Solutions
    • 4.10.3 Customized Solutions

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Component
      • 5.2.1.6 Application
      • 5.2.1.7 Process
      • 5.2.1.8 Deployment
      • 5.2.1.9 End User
      • 5.2.1.10 Solutions
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Component
      • 5.2.2.6 Application
      • 5.2.2.7 Process
      • 5.2.2.8 Deployment
      • 5.2.2.9 End User
      • 5.2.2.10 Solutions
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Component
      • 5.2.3.6 Application
      • 5.2.3.7 Process
      • 5.2.3.8 Deployment
      • 5.2.3.9 End User
      • 5.2.3.10 Solutions
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Component
      • 5.3.1.6 Application
      • 5.3.1.7 Process
      • 5.3.1.8 Deployment
      • 5.3.1.9 End User
      • 5.3.1.10 Solutions
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Component
      • 5.3.2.6 Application
      • 5.3.2.7 Process
      • 5.3.2.8 Deployment
      • 5.3.2.9 End User
      • 5.3.2.10 Solutions
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Component
      • 5.3.3.6 Application
      • 5.3.3.7 Process
      • 5.3.3.8 Deployment
      • 5.3.3.9 End User
      • 5.3.3.10 Solutions
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Component
      • 5.4.1.6 Application
      • 5.4.1.7 Process
      • 5.4.1.8 Deployment
      • 5.4.1.9 End User
      • 5.4.1.10 Solutions
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Component
      • 5.4.2.6 Application
      • 5.4.2.7 Process
      • 5.4.2.8 Deployment
      • 5.4.2.9 End User
      • 5.4.2.10 Solutions
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Component
      • 5.4.3.6 Application
      • 5.4.3.7 Process
      • 5.4.3.8 Deployment
      • 5.4.3.9 End User
      • 5.4.3.10 Solutions
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Component
      • 5.4.4.6 Application
      • 5.4.4.7 Process
      • 5.4.4.8 Deployment
      • 5.4.4.9 End User
      • 5.4.4.10 Solutions
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Component
      • 5.4.5.6 Application
      • 5.4.5.7 Process
      • 5.4.5.8 Deployment
      • 5.4.5.9 End User
      • 5.4.5.10 Solutions
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Component
      • 5.4.6.6 Application
      • 5.4.6.7 Process
      • 5.4.6.8 Deployment
      • 5.4.6.9 End User
      • 5.4.6.10 Solutions
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Component
      • 5.4.7.6 Application
      • 5.4.7.7 Process
      • 5.4.7.8 Deployment
      • 5.4.7.9 End User
      • 5.4.7.10 Solutions
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Component
      • 5.5.1.6 Application
      • 5.5.1.7 Process
      • 5.5.1.8 Deployment
      • 5.5.1.9 End User
      • 5.5.1.10 Solutions
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Component
      • 5.5.2.6 Application
      • 5.5.2.7 Process
      • 5.5.2.8 Deployment
      • 5.5.2.9 End User
      • 5.5.2.10 Solutions
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Component
      • 5.5.3.6 Application
      • 5.5.3.7 Process
      • 5.5.3.8 Deployment
      • 5.5.3.9 End User
      • 5.5.3.10 Solutions
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Component
      • 5.5.4.6 Application
      • 5.5.4.7 Process
      • 5.5.4.8 Deployment
      • 5.5.4.9 End User
      • 5.5.4.10 Solutions
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Component
      • 5.5.5.6 Application
      • 5.5.5.7 Process
      • 5.5.5.8 Deployment
      • 5.5.5.9 End User
      • 5.5.5.10 Solutions
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Component
      • 5.5.6.6 Application
      • 5.5.6.7 Process
      • 5.5.6.8 Deployment
      • 5.5.6.9 End User
      • 5.5.6.10 Solutions
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Component
      • 5.6.1.6 Application
      • 5.6.1.7 Process
      • 5.6.1.8 Deployment
      • 5.6.1.9 End User
      • 5.6.1.10 Solutions
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Component
      • 5.6.2.6 Application
      • 5.6.2.7 Process
      • 5.6.2.8 Deployment
      • 5.6.2.9 End User
      • 5.6.2.10 Solutions
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Component
      • 5.6.3.6 Application
      • 5.6.3.7 Process
      • 5.6.3.8 Deployment
      • 5.6.3.9 End User
      • 5.6.3.10 Solutions
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Component
      • 5.6.4.6 Application
      • 5.6.4.7 Process
      • 5.6.4.8 Deployment
      • 5.6.4.9 End User
      • 5.6.4.10 Solutions
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Component
      • 5.6.5.6 Application
      • 5.6.5.7 Process
      • 5.6.5.8 Deployment
      • 5.6.5.9 End User
      • 5.6.5.10 Solutions

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Ginkgo Bioworks
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Zymergen
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Arzeda
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Amyris
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Conagen
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Genomatica
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Pivot Bio
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Synthace
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Benchling
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Inscripta
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Twist Bioscience
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Cambrium
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Evonetix
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Cellibre
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Molecular Assemblies
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us